Serum Institute of India Given Green Light to Resume Clinical Trials of AstraZeneca COVID Vaccine

Clinical trials for the Oxford vaccine candidate were suspended in India last week after a participant in the UK reported an “unexplained illness” during the study. The Serum Institute of India is partnering with the University of Oxford and pharmaceutical company AstraZeneca to manufacture a COVID-19 vaccine in India.

Source: Sputnik News

Powered by WPeMatico


Newsletter

 Sign up now to receive our Daily Newsletters, straight to your inbox.